Oncolytics Biotech Inc (ONCY)
1.05
+0.01
(+0.96%)
USD |
NASDAQ |
Apr 24, 16:00
1.05
0.00 (0.00%)
After-Hours: 18:47
Oncolytics Biotech Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2007 | -1.19K% |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | -1.07K% |
| June 30, 2006 | -892.7% |
| March 31, 2006 | -1.02K% |
| December 31, 2005 | |
| September 30, 2005 | -1.66K% |
| June 30, 2005 | -1.76K% |
| March 31, 2005 | -971.6% |
| December 31, 2004 | |
| September 30, 2004 | -1.60K% |
| June 30, 2004 | -1.74K% |
| March 31, 2004 | -2.28K% |
| December 31, 2003 | -1.34K% |
| Date | Value |
|---|---|
| September 30, 2003 | -1.79K% |
| June 30, 2003 | -9.46K% |
| March 31, 2003 | -2.58K% |
| December 31, 2002 | -3.47K% |
| September 30, 2002 | -3.77K% |
| June 30, 2002 | -2.36K% |
| March 31, 2002 | -2.23K% |
| December 31, 2001 | |
| September 30, 2001 | |
| June 30, 2001 | -87.98M% |
| March 31, 2001 | -66.42M% |
| December 31, 2000 | -164.9% |
| September 30, 2000 | -105.2M% |
| June 30, 2000 | -86.04M% |
| March 31, 2000 | -18.57M% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |